Trial Profile
Special drug use survey of Tremfya for Psoriasis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Jun 2018
Price :
$35
*
At a glance
- Drugs Guselkumab (Primary)
- Indications Erythrodermic psoriasis; Generalised pustular psoriasis; Plaque psoriasis; Psoriasis; Psoriatic arthritis
- Focus Adverse reactions
- Acronyms TRM1L
- Sponsors Janssen Pharmaceutical KK
- 14 Jun 2018 New trial record